
Megan Sheehan of Sheehan & Associates, Attorneys representing MMJ International Holdings and MMJ BioPharma Cultivation etal, scheduled to execute on clinical trials in Huntington's disease and multiple sclerosis, filed a motion in federal court against the Drug Enforcement Administration, asking the federal court for "an emergency motion for irreparable damages".
This motion will hopefully induce the DEA to respond promptly to MMJ's application to manufacture marijuana for research purposes according to the DEA's self mandated timeline.